The Drug Cost Transparency Act requires pharmaceutical manufacturers to report on prescription drugs that cost $100 or more for a month supply as outlined in Chapter 441, §441.002 (c). The price increase data is displayed below and can be downloaded here.

 

Last updated: 08/12/2021

Search by brand/generic name or manufacturer
Name Manufacturer Drug type NDC 11 Purpose of report Date of price increase
DOPTELET AkaRx Inc. T 71369002010 15 percent increase 07/01/2021
GLIPIZIDE TAB 10MG 10000 BTL USA Apotex Corp G 60505014204 15 percent increase 05/18/2021
Gammaked 10% 200ML Vial Kedrion Biopharma Inc. T 76125090020 15 percent increase 05/02/2021
Gammaked 10% 100ML Vial Kedrion Biopharma Inc. T 76125090010 15 percent increase 05/02/2021
Gammaked 10% 10ML Vial Kedrion Biopharma Inc. T 76125090001 15 percent increase 05/02/2021
Gammaked 10% 50ML Vial Kedrion Biopharma Inc. T 76125090050 15 percent increase 05/02/2021
Jeanatope Iso-Tex Diagnostics, Inc. T 5091477329 40 percent increase 04/19/2021
Valstar Endo Pharmaceuticals Inc. T 67979000101 15 percent increase 04/01/2021
SUPPRELIN Endo Pharmaceuticals Inc. T 67979000201 15 percent increase 04/01/2021
Vantas Endo Pharmaceuticals Inc. T 67979050001 15 percent increase 04/01/2021
Aveed Endo Pharmaceuticals Inc. T 67979051143 15 percent increase 04/01/2021
Valstar Endo Pharmaceuticals Inc. T 67979000101 40 percent increase 04/01/2021
SUPPRELIN Endo Pharmaceuticals Inc. T 67979000201 40 percent increase 04/01/2021
INDERAL LA ANI Pharmaceuticals, Inc T 62559052101 15 percent increase 03/05/2021
INDERAL LA ANI Pharmaceuticals, Inc T 62559052001 40 percent increase 03/05/2021